aquinnahpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* | ||
Meta Tags
| Title | Aquinnah |
| Description | A BOLD NEW APPROACH TO NEURODEGENERATIVE DISEASE - ALS and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.49.23.145 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
aquinnahpharma.com Valuation
|
US$3,749,420
Last updated: 2022-07-05 19:55:36
aquinnahpharma.com has Semrush global rank of 2,822,918. aquinnahpharma.com has an estimated worth of US$ 3,749,420, based on its estimated Ads revenue. aquinnahpharma.com receives approximately 432,626 unique visitors each day. Its web server is located in United States, with IP address 198.49.23.145. According to SiteAdvisor, aquinnahpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,749,420 |
| Daily Ads Revenue | US$3,462 |
| Monthly Ads Revenue | US$103,831 |
| Yearly Ads Revenue | US$1,245,961 |
| Daily Unique Visitors | 28,842 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| aquinnahpharma.com. | A | 600 | IP: 198.49.23.145 |
| aquinnahpharma.com. | A | 600 | IP: 198.185.159.144 |
| aquinnahpharma.com. | A | 600 | IP: 198.185.159.145 |
| aquinnahpharma.com. | A | 600 | IP: 198.49.23.144 |
| aquinnahpharma.com. | NS | 3600 | NS Record: ns06.domaincontrol.com. |
| aquinnahpharma.com. | NS | 3600 | NS Record: ns05.domaincontrol.com. |
| aquinnahpharma.com. | MX | 600 | MX Record: 0 aquinnahpharma-com.mail.protection.outlook.com. |
| aquinnahpharma.com. | TXT | 600 | TXT Record: MS=ms32355250 |
| aquinnahpharma.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| aquinnahpharma.com. | TXT | 600 | TXT Record: google-site-verification=0ywukNZB-U5BnkgdDVld5h-4ljYkt5WmLFy3xCa9BdA |
HtmlToTextCheckTime:2022-07-05 19:55:36
| Home The Work The Team News CAREERS Contact Home The Work The Team News CAREERS Contact A bold new approach to neurodegenerative disease The Growing Threat A bold new approach to neurodegenerative disease SCROLL DOWN A bold new approach to neurodegenerative disease Our discovery of the connection between stress granules and neurodegenerative disease is one of the most promising developments today and could offer amazing new hope for patients and their families. We are harnessing our years of experience studying biomolecular condensates, stress granules and RNA binding proteins to discover and develop small molecules for neurodegenerative diseases with clear unmet medical need. This potential breakthrough is especially significant after years of disappointment in ALS and Alzheimer’s research. The strength of our science is the result of a long commitment to neurodegenerative research, exacting standards and a fresh, out-of-the-box approach. We have been awarded numerous peer-reviewed |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 133444 Date: Wed, 27 Oct 2021 16:30:55 GMT Location: https://www.aquinnahpharma.com/ Server: Squarespace Set-Cookie: crumb=BYXqT5mapoN7OTA1NmY1YjBmYjI4MWM0MWQ0ODcyMTAxN2M3MDYw;Path=/ X-Contextid: KLuvUnFX/v969W6hP HTTP/2 200 accept-ranges: bytes age: 133383 content-type: text/html;charset=utf-8 date: Wed, 27 Oct 2021 16:31:56 GMT etag: W/"a5cf2dc675f388501d8830a2eda28b80--gzip" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BZp9m4tl9hd6MDRkZTNjMGIxY2M1ZTZiY2Q4ODE3MzhlNjcwMjU1;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: bzaUJf51/uOfFbpW3 |
aquinnahpharma.com Whois Information
Domain Name: AQUINNAHPHARMA.COM Registry Domain ID: 1842489684_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-04-10T19:51:00Z Creation Date: 2014-01-12T16:08:55Z Registry Expiry Date: 2024-01-12T16:08:55Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS05.DOMAINCONTROL.COM Name Server: NS06.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T19:55:15Z <<< |